Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Baxter Has Much Room for Growth in Japan: President Kawabata
February 25, 2008
- R&D NEWS IN BRIEF
February 25, 2008
- Korosho to Meet Concerned Parties to Improve Drug Distribution Practices
February 25, 2008
- OPINION／The Hottest Jobs in 2008 Revealed
February 25, 2008
- SSP to Promote Core Brand Strategy Based on 8 Products
February 25, 2008
- MEDICAL DEVICE NEWS IN BRIEF
February 25, 2008
- AZ Trains District Managers to Enhance Its Sales Forces
February 25, 2008
- Mediceo Paltac to Deal with Generics in Earnest
February 25, 2008
- Novartis to Launch Galvus in Europe
February 25, 2008
- Hansha Must Deal with Generics from All Companies: Mr Eguchi of Seibu Sawai
February 25, 2008
- FY2008 Revision of Medical Fees Recommended by Chuikyo
February 25, 2008
- Premium of 4 Points to Be Paid to Heavy Generic Dispensers
February 25, 2008
- BUSINESS NEWS IN BRIEF
February 25, 2008
- Generics to Be NHI Price Listed in May and November from FY2009
February 25, 2008
- NHI Pricing Procedures to See Changes
February 25, 2008
- TOPICS／Poster Prepared by Korosho to Promote Use of Generics
February 25, 2008
- JPA Satisfied with Proposed Dispensing Fees: JPA Vice President
February 25, 2008
- Piecework System Should Be Applied to Drugs Used at Nursing Care Facilities
February 25, 2008
- JPMA to Cooperate in Reduction in CO2 Emission
February 18, 2008
- Requirements for Self-injection of IFN, Etanercept Relaxed
February 18, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…